CDW vs MREO · P/E 22, rev $12.25B vs $48.7M cap
CDW Corp (CDW) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
CDW Corp (CDW) is a information technology services company listed on US.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported CDW revenue for 2026-06-30 was $12.25B. Net income was $509.8M. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
CDW currently screens at market cap $23.36B and trailing P/E 22.0. MREO currently screens at market cap $48.7M.
Not investment advice. Open the CDW and MREO stock pages for the full models.
Not investment advice.